Bonesupport Holding AB (publ) Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 57 Fair Values set on narratives written by author
BONEX Community Narratives
Positive Clinical Results And US Launch Will Drive Future Success
Slow Trauma Center Adoption And Regulatory Hurdles Will Eventually Support A Healthier Business Mix
US Trauma Expansion And New Surgical Uses Will Transform This Bone Regeneration Specialist
Positive Clinical Results And US Launch Will Drive Future Success
View narrativeSlow Trauma Center Adoption And Regulatory Hurdles Will Eventually Support A Healthier Business Mix
View narrativeUS Trauma Expansion And New Surgical Uses Will Transform This Bone Regeneration Specialist
View narrativeTrending Discussion
No trending discussion available.
Recently Updated Narratives
BONEX: Share Buybacks Will Support Bullish Case Despite Lowered Growth Assumptions
BONEX: Share Buybacks And Margin Strength Will Drive Future Upside
US Trauma Expansion And New Surgical Uses Will Transform This Bone Regeneration Specialist
Snowflake Analysis
Bonesupport Holding AB (publ) Key Details
- 3.27
- 92.05%
- 16.63%
- 0%
About BONEX
- Founded
- 1999
- Employees
- 171
- CEO
- Website
View website
Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.